Chemical Bank’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,855
| Closed | -$201K | – | 348 |
|
|
2019
Q1 | $201K | Buy |
+3,855
| New | +$193K | 0.02% | 340 |
|
|
2018
Q4 | – | Sell |
-4,015
| Closed | -$202K | – | 350 |
|
|
2018
Q3 | $202K | Sell |
4,015
-145
| -3% | -$7.37K | 0.02% | 357 |
|
|
2018
Q2 | $210K | Sell |
4,160
-104
| -2% | -$5.24K | 0.02% | 348 |
|
|
2018
Q1 | $208K | Sell |
4,264
-840
| -16% | -$39.1K | 0.02% | 356 |
|
|
2017
Q4 | $226K | Sell |
5,104
-480
| -9% | -$22.2K | 0.02% | 345 |
|
|
2017
Q3 | $283K | Sell |
5,584
-8,310
| -60% | -$422K | 0.03% | 319 |
|
|
2017
Q2 | $749K | Sell |
13,894
-181
| -1% | -$9.65K | 0.08% | 200 |
|
|
2017
Q1 | $742K | Buy |
14,075
+204
| +1% | +$10.3K | 0.08% | 196 |
|
|
2016
Q4 | $668K | Buy |
13,871
+1,091
| +9% | +$53.9K | 0.08% | 200 |
|
|
2016
Q3 | $689K | Sell |
12,780
-120
| -0.9% | -$6.58K | 0.09% | 175 |
|
|
2016
Q2 | $699K | Sell |
12,900
-289
| -2% | -$15.2K | 0.1% | 176 |
|
|
2016
Q1 | $668K | Buy |
13,189
+80
| +0.6% | +$3.98K | 0.09% | 180 |
|
|
2015
Q4 | $661K | Sell |
13,109
-855
| -6% | -$43.6K | 0.09% | 179 |
|
|
2015
Q3 | $672K | Sell |
13,964
-1,740
| -11% | -$90.6K | 0.1% | 184 |
|
|
2015
Q2 | $817K | Sell |
15,704
-320
| -2% | -$18K | 0.11% | 179 |
|
|
2015
Q1 | $925K | Buy |
16,024
+40
| +0.3% | +$2.29K | 0.12% | 167 |
|
|
2014
Q4 | $854K | Buy |
15,984
+720
| +5% | +$40.3K | 0.11% | 180 |
|
|
2014
Q3 | $877K | Buy |
15,264
+5,660
| +59% | +$347K | 0.15% | 142 |
|
|
2014
Q2 | $642K | Buy |
9,604
+1,200
| +14% | +$81.2K | 0.11% | 170 |
|
|
2014
Q1 | $561K | Sell |
8,404
-1,242
| -13% | -$84K | 0.1% | 175 |
|
|
2013
Q4 | $644K | Hold |
9,646
| – | – | 0.11% | 164 |
|
|
2013
Q3 | $605K | Sell |
9,646
-280
| -3% | -$18K | 0.12% | 166 |
|
|
2013
Q2 | $620K | Buy |
+9,926
| New | +$630K | 0.12% | 160 |
|
Other funds holding GSK
BCIM
